2
H-index
10
Jumlah Petikan /
Total Citation

dr. nur fa`izah binti ab muin

pensyarah perubatan

jabatan radiologi

 drfaizah_abmuin@ukm.edu.my



   Biografi/ Biography :






    •     Data Bibliometrik / Bibliometric Data
    Nota : Jumlah penerbitan adalah berdasarkan dari tahun pertama berkhidmat di UKM.
    Note : The number of publication is based from the first year working in UKM.
       Penerbitan Terkini / Latest Publication

    nor aniza azmi, nurul uzma noor hisham, caryn chan mei hsien, nur faizah ab muin, ahmad syahmiuddin, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2025).  bridging the empathy gap: psycho-oncology training and the future of patient-centered radiotherapy.  - the 25th asia-australasia conference of radiological technologists (aacrt 2025) conference.  65 - 65. 

     

    izzati yussof, noraida mohamed shah, sarahfarina abd. rahim, nur fa'izah ab muin, nor asyikin mohd tahir, ernieda hatah.  (2025).  expert validation of an educational tool for breast cancer patients on endocrine therapy.  - national oncology pharmacy conference (nopc 4.0).  . 

     

    nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro.  . 

     

    hui ting eyu, nik ruzyanei nik jaafar, mohammad farris iman leong abdullah, hajar mohd salleh salimi, mohd razif mohamad yunus, fuad ismail, nur fa'izah ab muin, noor syazwani abdul aziz.  (2024).  perceived shame and stigma, and other psychosocial predictors of psychological distress among cancer patients in malaysia.  - psycho-oncology.  1 - 9. 

     

    nur faizah ab muin, marniza saad, adlinda alip, muthukkumaran thiagarajan.  (2024).  the outcomes of glioblastoma multiforme: the university malaya medical centre experience 2008-2018.  - journal of health and translational medicine.  49-56. 

     
    Lihat Seterusnya/More
       Penerbitan Berimpak Tinggi / High Impact Publication

    hui ting eyu, nik ruzyanei nik jaafar, mohammad farris iman leong abdullah, hajar mohd salleh salimi, mohd razif mohamad yunus, fuad ismail, nur fa'izah ab muin, noor syazwani abdul aziz.  (2024).  perceived shame and stigma, and other psychosocial predictors of psychological distress among cancer patients in malaysia.  - psycho-oncology.  1 - 9. 

     

    nur faizah ab muin; marniza saad; adlinda alip; muthukkumaran thiagarajan.  (2023).  the outcomes of glioblastoma multiforme:the university malaya medical centre experience 2008-2018.  - annals of oncology.  S1411. 

     

    izzati yussof, nur faizah ab muin, masnizah mohd, ernieda hatah, nor asyikin mohd tahir, noraida mohamed shah.  (2023).  breast cancer prevention and treatment misinformation on twitter: an analysis of two languages.  - digital health.  1-11. 

     
       Penerbitan WOS / WOS Publication

    izzati yussof, noraida mohamed shah, nur fa’izah ab muin, sarahfarina abd. rahim, ernieda hatah, nor asyikin mohd tahir, kavinash loganathan, murallitharan munisamy.  (2024).  challenges in obtaining and seeking information among breast cancer survivors in an asian country: a qualitative study.  - journal of cancer education.  383 - 390. 

     
       Penerbitan SCOPUS/ERA / SCOPUS/ERA Publication

    nur faizah ab muin, marniza saad, adlinda alip, muthukkumaran thiagarajan.  (2024).  the outcomes of glioblastoma multiforme: the university malaya medical centre experience 2008-2018.  - journal of health and translational medicine.  49-56. 

     

    nor aniza azmi, caryn chan mei hsien, nur fa'izah ab muin, ahmad syahmiuddin shamsuddin, nur afiqah mohd shukri, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2024).  innovative training for future radiation therapists: designing a student-centric psychosocial and supportive cancer patient care [psosc] module in malaysia.  - journal of medical imaging and radiation sciences.  45 - 45. 

     

    hui ting eyu, nik ruzyanei nik jaafar, mohammad farris iman leong abdullah, hajar mohd salleh salimi, mohd razif mohamad yunus, fuad ismail, nur fa'izah ab muin, noor syazwani abdul aziz.  (2024).  perceived shame and stigma, and other psychosocial predictors of psychological distress among cancer patients in malaysia.  - psycho-oncology.  1 - 9. 

     

    izzati yussof, nur fa’izah ab muin, rick sheng tan, masnizah mohd, ernieda hatah, nor asyikin mohd tahir, noraida mohamed shah.  (2024).  breast cancer misinformation in facebook and twitter: a bilingual analysis.  - pharmacy education.  205 - 206. 

     

    izzati yussof, noraida mohamed shah, nur fa’izah ab muin, sarahfarina abd. rahim, ernieda hatah, nor asyikin mohd tahir, kavinash loganathan, murallitharan munisamy.  (2024).  challenges in obtaining and seeking information among breast cancer survivors in an asian country: a qualitative study.  - journal of cancer education.  383 - 390. 

     
    Lihat Seterusnya/More
       Penulisan Dalam Bahasa Melayu / Writing In Bahasa Melayu

    nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro.  . 

     
       Penerbitan Lain-lain / Other Publication

    nur fa'izah ab muin.  (2025).  angin pasang atau kanser testis.  - harian metro.  . 

     

    nor aniza azmi, nurul uzma noor hisham, caryn chan mei hsien, nur faizah ab muin, ahmad syahmiuddin, mimi syaqirah ab razak, aminul haqim mohd nizam.  (2025).  bridging the empathy gap: psycho-oncology training and the future of patient-centered radiotherapy.  - the 25th asia-australasia conference of radiological technologists (aacrt 2025) conference.  65 - 65. 

     

    izzati yussof, noraida mohamed shah, sarahfarina abd. rahim, nur fa'izah ab muin, nor asyikin mohd tahir, ernieda hatah.  (2025).  expert validation of an educational tool for breast cancer patients on endocrine therapy.  - national oncology pharmacy conference (nopc 4.0).  . 

     

    nur afifah mursyida zaujan, mohd razif shahril, suzana shahar, ezanee azlina mohamad hanif, rohaizak muhammad, fuad ismail, nur fa’izah ab muin, razinah sharif, ponnusamy subramaniam, azizi abdullah, michael fenech.  (2024).  dietary choices and their impact on telomere length: implications for women's health.  - 5th apnno biennial conference 2024 & 14th asia pacific conference on clinical nutrition.  105 - 105. 

     

    izzati yussof, noraida mohamed shah, nur fa’izah ab muin, sarahfarina abd. rahim, ernieda hatah, nor asyikin mohd tahir, kavinash loganathan, murallitharan munisamy.  (2024).  “internet era”: a qualitative study of online information-seeking among breast cancer patients on adjuvant endocrine therapy.  - 12th national pharmacy r&d conference 2024.  . 

     
    Lihat Seterusnya/More
       Geran Kolaborasi Terkini / Latest Collaboration Grant
    Geran / Grant Kolaborator / Collaborator Status
    A PHASE 3 STUDY TO EVALUATE ZIMBERELIMAB (AB122) MONOTHERAPY COMPARED TO STANDARD CHEMOTHERAPY OR ZIMBERELIMAB COMBINED WITH AB154 IN FRONT-LINE, PD-L1-POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER arcus biosciences inc
    93.6% (2021-03-25 sehingga 2025-12-24)
    PHASE 1 STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF THE ANTI‑OX40 AGONIST MONOCLONAL ANTIBODY BGB-A445 IN COMBINATION WITH THE ANTI-PD-1 MONOCLONAL ANTIBODY TISLELIZUMAB IN PATIENTS WITH ADVANCED S beigene singapore pte. ltd
    94% (2022-11-10 sehingga 2025-11-09)
    A RANDOMIZED, OPEN-LABEL PHASE 2/3 STUDY OF BT8009 AS MONOTHERAPY OR IN COMBINATION IN PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (DURAVELO-2) bicycletx limited
    16.7% (2024-07-25 sehingga 2031-03-24)
    A GLOBAL, PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FURMONERTINIB COMPARED TO PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINETREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCE arrivent biopharma, inc
    36.2% (2023-07-27 sehingga 2029-05-26)
    A RANDOMIZED, DOUBLE-BLIND STUDY EVALUATING THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF ABP 206 COMPARED WITH OPDIVO® (NIVOLUMAB) IN SUBJECTS WITH TREATMENT-NAïVE UNRESECTABLE OR METASTATIC MELANOMA parexel international (malaysia) sdn bhd
    44.5% (2024-01-04 sehingga 2027-10-03)
    Lihat Seterusnya/More
    A PHASE III, OPEN-LABEL, SPONSOR-BLIND, RANDOMIZED STUDY OF DATO-DXD WITH OR WITHOUT OSIMERTINIB VERSUS PLATINUM-BASED DOUBLET CHEMOTHERAPY FOR PARTICIPANTS WITH EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS... astrazeneca ab
    44.5%(2024-09-26 sehingga 2028-03-25)
    A PHASE III, OPEN-LABEL, SPONSOR-BLIND, RANDOMIZED STUDY OF DATO-DXD WITH OR WITHOUT OSIMERTINIB VERSUS PLATINUM-BASED DOUBLET CHEMOTHERAPY FOR PARTICIPANTS WITH EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS... parexel international (malaysia) sdn bhd.
    44.5%(2024-09-26 sehingga 2028-03-25)
    THE CORRELATION OF PD-L1 POSITIVITY WITH DNA MISMATCH REPAIR AND THEIR ASSOCIATIONS WITH TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER PATIENTS biomarketing services (m) sdn. bhd.
    44.5%(2024-11-01 sehingga 2026-10-31)
    THE CORRELATION OF PD-L1 POSITIVITY WITH DNA MISMATCH REPAIR AND THEIR ASSOCIATIONS WITH TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER PATIENTS jabatan patologi, hospital putrajaya
    44.5%(2024-11-01 sehingga 2026-10-31)
    A RANDOMIZED, DOUBLE-BLIND STUDY EVALUATING PHARMACOKINETIC SIMILARITY OF ABP 206 COMPARED WITH OPDIVO® (NIVOLUMAB) IN RESECTED STAGE III OR STAGE IV MELANOMA SUBJECTS IN THE ADJUVANT SETTING parexel international (malaysia) sdn bhd
    44.5%(2023-06-22 sehingga 2026-08-21)
    ELACESTRANT VERSUS STANDARD ENDOCRINE THERAPY INWOMEN AND MEN WITH NODE-POSITIVE, ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE, EARLY BREAST CANCER WITHHIGH RISK OF RECURRENCE—A GLOBAL, MULTICENTER, RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (ELEGANT) stemline therapeutics, inc.
    44.5%(2025-01-09 sehingga 2033-01-08)
       Projek Penyelidikan / Research Projects
    Projek / Project Tempoh / Period Peranan / Role
    elacestrant versus standard endocrine therapy inwomen and men with node-positive, estrogen receptor-positive, her2-negative, early breast cancer withhigh risk of recurrence—a global, multicenter, randomized, open-label phase 3 study (elegant) 09-01-202508-01-2033 Ketua Projek
    a randomized, open-label phase 2/3 study of bt8009 as monotherapy or in combination in participants with locally advanced or metastatic urothelial cancer (duravelo-2) 25-07-202424-03-2031 Ketua Projek
    exploring nuclear security culture: a questionnaire-based survey 16-05-202415-11-2025 Ketua Projek
    fatigue among head and neck cancer patients undergoing radiotherapy: a multimodal radiomics-based prediction model 16-06-202515-06-2026 Penyelidik Bersama
    a phase 3 open-label, randomized, active-controlled, multicenter trial to evaluate the efficacy and safety of orally administered bay 2927088 compared with standard of care as a first-line therapy in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with her2-activating mutations. 06-01-202505-09-2028 Penyelidik Bersama
    Lihat Seterusnya/More
       Bidang Kepakaran / Area of Expertise
    Nota : Maksimum 5 Bidang Kepakaran yang terkini dipaparkan./ Note : Maximum of 5 latest Area of Expertise is viewed.
       Pelajar Seliaan / Supervised Student
    3

    Sarjana /
    Master
    2

    Doktor Falsafah /
    Philosophy Doctor